OTC · Medical - Pharmaceuticals

Abattis Bioceuticals Corp. (ATTBF) Stock

$0.00 OTC: ATTBF Healthcare

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada.

Valuation

MetricValue
Price$0.00
Market Cap$14334
P/E Ratio-0.01
P/B Ratio0.00
P/S Ratio0.04
EPS (TTM)$-0.02
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-28.13%
ROA-15.94%
ROCE-27.58%
Gross Margin67.63%
Operating Margin-217.34%
Net Margin0.00%
Debt/Equity0.01
Current Ratio0.73

Annual Financials (USD)

Metric20152016201720182019
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-2.0M$-6.0M$-17.0M$-4.0M
Net Profit$-4.0M$-2.0M$-8.0M$-78.0M$-3.0M
EPS$-0.06$-0.02$-0.05$-0.24$-0.01
Op Margin-3347.6%——-207542.2%-1108.7%

Balance Sheet (USD)

Metric20152016201720182019
Total Assets$2.0M$1.0M$1.0M$11.0M$19.0M
Total Liabilities$1.0M$1.0M$0$0$9.0M
Cash$0$0$1.0M$4.0M$2.0M
Borrowings$0$0$0$0$2.0M

Cash Flow (USD)

Metric20152016201720182019
Operating Cash Flow$-2.0M$-1.0M$-1.0M$-8.0M$9.0M
Investing Cash Flow$1.0M$0$-1.0M$-16.0M$-17.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$4.0M$-2.0M
Free Cash Flow$-2.0M$-1.0M$-2.0M$-9.0M$4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.15
FCF Yield21772.55%
Quick Ratio0.68
Interest Coverage-80.16
Return 1Y200.00%
Return 3Y200.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Abattis Bioceuticals Corp. (ATTBF) stock trades at $0.00 with a market capitalization of $14334. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.00, price-to-sales of 0.04. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Abattis Bioceuticals Corp. generates a return on equity (ROE) of -28.13%, return on capital employed of -27.58%, an operating margin of -217.34%, a net profit margin of 0.00%.

Official website: www.abattis.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides